Knowledge about the pathogenesis, diagnosis, and management of glomerular diseases is advancing rapidly. In this program, a panel of international experts discusses the advances using lectures, interactive case-based discussions, self-assessment questions, and panel discussions. Participants learn clinical applications as they review updates in treatments, pathology, genetics, and glomerular diseases in special populations. You can listen, watch, and learn from on-demand presentations in advance of two live-stream clinicopathologic case sessions.
Course Objective(s)
Upon completion of the program, the participant will be able to:
1) describe and integrate the pathology, diagnosis, and therapeutic options for glomerular diseases
2) integrate information from current basic and clinical research studies and apply them to the diagnosis and management of glomerular disorders
3) analyze nuances in the treatment of patients with difficult glomerular diseases.
Content
On Demand
Presentations
Pathology of Dysproteinemias
Glen S. Markowitz, MD
Diagnostic and Clinical Approach in the Management of Dysproteinemias
Nelson Leung, MD
Management of ANCA-Associated Vasculitis
Rachel B. Jones, MBBS, MD
Viral Glomerulopathies: Comparing HIV-Associated Nephropathy and COVID-19-Associated Nephropathy
John Cijiang He, MD, PhD, FASN
Progress in the Clinical Approach to IgA Nephropathy
Heather N. Reich, MD, PhD
Glomerular Disease in Pregnancy
Liz Lightstone, MBBS, PhD
Using Traditional and Novel Treatments to Slow Progression of Diabetic Kidney Disease and Cardiovascular Comorbidities
Katherine R. Tuttle, MD, FASN
Management of Lupus Nephritis: How and When to Use the New Tools in the Toolbox
Brad H. Rovin, MD, FASN
Nephrotic Syndrome Diagnosis and Management: Traditional and Novel Approaches
Miriam Chung, MD
Pathology of FSGS and Membranous Nephropathy
Cynthia C. Nast, MD, FASN
Management of Minimal Change Disease and FSGS
J. Ashley Jefferson, MD, FASN
Pathobiology and Management of Membranous Nephropathy
Laurence H. Beck, MD, PhD
Glomerular Disease in Children
Rasheed A. Gbadegesin, MBBS, MD, FASN
APOL1-Associated Kidney Disease: Mechanisms and Clinical Applications
Martin Pollak, MD
C3 Glomerulopathy and Atypical Hemolytic Uremic Syndrome: Morphology and Clinical Approach
Cynthia C. Nast, MD, FASN
Carla Marie Nester, MD, MS, FASN
KDIGO 2021 and Beyond: Changing Your Treatment Approaches
Sharon G. Adler, MD, FASN
Livestream 1
Presentations
Welcome and Introduction – Co-Chairs
10:00 AM EDT – 10:05 AM EDT
Nephritic Syndrome: Live Clinical Pathology Conference
10:05 AM EDT – 11:35 AM EDT
Glen S. Markowitz, MD
Pietro A. Canetta, MD, MS
Applying the Lessons of the Day
11:35 AM EDT – 12:00 PM EDT
Glen S. Markowitz, MD
Nelson Leung, MD
Rachel B. Jones, MBBS, MD
John Cijiang He, MD, PhD, FASN
Heather N. Reich, MD, PhD
Katherine R. Tuttle, MD, FASN
Brad H. Rovin, MD, FASN
Livestream 2
Presentations
Welcome and Introduction – Co-Chairs
04:00 PM EDT – 04:05 PM EDT
Nephrotic Syndrome: Live Clinical Pathology Conference
04:05 PM EDT – 05:35 PM EDT
Jean Hou, MD
Dechu P. Puliyanda, MD
Phuong-Chi T. Pham, MD, FASN
Madeleine V. Pahl, MD, FASN
Applying the Lessons of the Day
05:35 PM EDT – 06:00 PM EDT
Miriam Chung, MD
Cynthia C. Nast, MD, FASN
J. Ashley Jefferson, MD, FASN
Laurence H. Beck, MD, PhD
Rasheed A. Gbadegesin, MBBS, MD, FASN
Martin Pollak, MD
Carla Marie Nester, MD, MS, FASN